You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Evaluation of the 100% Recyclability of Superpave Hot Mix Asphalt

    SBC: HIP Paving, LLC            Topic: A

    "At 2.7 million miles of paved roads, the United States has the largest network of roads in the world. The mainstream approach to pavement rehabilitation has been to mill the deteriorated asphalt and replace with new asphalt mix. The hot in-place pavement recycling process has the potential of replacing the milling and resurfacing process with substantial financial and environmental savings. Ho ...

    SBIR Phase I 2011 Environmental Protection Agency
  2. Novel Membranes for Natural Gas Dehydration

    SBC: MEMBRANE TECHNOLOGY AND RESEARCH, INC.            Topic: B

    "Before entering the national pipeline distribution system, all natural gas must be dried, which is currently achieved using glycol dehydrators. However, the glycol dehydrators extract hazardous volatile organic compounds (VOCs) from the raw natural gas streams, In the U.S. alone the VOC emissions from dehydrators total an estimated 44,000 tons per year, half of which are benzene, toluene, ethyl ...

    SBIR Phase I 2011 Environmental Protection Agency
  3. Combination of Chlorine-Free Electrolytic and Photochemical Methods for Sterilization of Contaminated Waters

    SBC: MICRO-TRACERS INC            Topic: F

    "Effective electrolytic sanitizing of contaminated waters using chloride requires a relatively high concentration of the elemental chlorine and hypochlorides. This requires a high concentration of chloride salt (higher the 0.15%). At such a concentration, chloride ions cause corrosion of various bimetal connections found in water plumbing systems, such as water distributors, cooling towers, etc. ...

    SBIR Phase I 2011 Environmental Protection Agency
  4. Electrical System for Rapid Bacterial Cultures

    SBC: TECHSHOT, INC.            Topic: NIAID

    DESCRIPTION (provided by applicant): The broad, long-term objective of the proposed project Electrical System for Rapid Bacterial Cultures is to develop an automated electrical impedance analyzer for measuring bacterial growth in contaminated blood. Thepurpose of the System is to hasten the time to diagnose sepsis from 1-2 days down to a few hours. The specific aims of the project are to (1) bui ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  5. A transfollicular nanovaccine against leishmaniasis

    SBC: VINDICO NANOBIOTECHNOLOGY, INC.            Topic: NIAID

    DESCRIPTION (provided by applicant): The World Health Organization estimates that over 350 million people are at risk of developing leishmaniasis and infection prevalence is 14 million people in the world. Annually, 2 million people are infected with Leishmania species and 270,000 will die. Leishmaniasis is one of the most important parasitic diseases affecting the U.S. military today, with over 2 ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  6. Therapeutic Antibodies for Rabies

    SBC: TRELLIS BIOSCIENCE, INC.            Topic: NIAID

    DESCRIPTION (provided by applicant): Trellis Bioscience has developed its patented CellSpot technology into a robust platform for characterizing the secreted antibody from single human lymphocytes with regard to specificity and affinity against multiple antigens. For example, the platform was used to isolate a rare, high quality human antibody to Respiratory Syncytial Virus (RSV) that is now bein ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  7. Therapeutic Antibodies for Bacteria

    SBC: TRELLIS BIOSCIENCE, INC.            Topic: NIAID

    DESCRIPTION (provided by applicant): Trellis Bioscience has developed its patented CellSpot technology into a robust platform for characterizing the secreted antibody from single human lymphocytes with regard to specificity and affinity against multiple antigens. For example, the platform was used to isolate a rare, high quality human antibody to Respiratory Syncytial Virus (RSV) that is now bein ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  8. Identification of novel influenza antivirals

    SBC: ARISAN THERAPEUTICS INC            Topic: NIAID

    DESCRIPTION (provided by applicant): The influenza A virus represents one of the greatest global human health risks. Although vaccines provide significant protection from seasonal flu infections they still account for an estimated 36,000 deaths and 200,000hospitalizations per year in the US alone. Furthermore, the inherent time involved in development, production and distribution of vaccines limit ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  9. A Combination Therapy Approach to Treating Drug Resistant Fungal Infections

    SBC: Amplyx Pharmaceuticals, Inc.            Topic: NIAID

    DESCRIPTION (provided by applicant): There is an urgent need to discover more effective therapeutic regimens for fungal infections. Nosocomial infections caused by Candida albicans have a 50% mortality rate. Aspergillosis is a leading cause of death in organ transplant recipients, as well as patients suffering from cancer and auto-immune disorders. The annual cost of treating fungal infections is ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  10. Origami MALE CONDOM-3: Feasibility and Acceptability Study, Phase 1 Clinical Resear

    SBC: Strata Various Product Design            Topic: NIAID

    DESCRIPTION (provided by applicant): The primary objective of this project is to build on prior Phase 1 research to improve product sensitivity properties, to refine and test modifications of the Origami Male Condom 1 (OMC 1), and develop a more consumer-acceptable device exclusively for vaginal-penile intercourse, the Origami Male Condom 3 (OMC 3). Made of custom formulated biocompatible, viral-i ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government